These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 26072064

  • 1. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
    Xiao J, Chen W, Lu Y, Zhang X, Fu C, Yan Z, Zhang Z, Ye Z.
    Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
    [Abstract] [Full Text] [Related]

  • 2. Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy.
    Xiao J, Leung JC, Chan LY, Tang SC, Lai KN.
    Clin Immunol; 2009 Aug; 132(2):266-76. PubMed ID: 19443277
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
    Ohama Y, Harada T, Iwabe T, Taniguchi F, Takenaka Y, Terakawa N.
    Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
    [Abstract] [Full Text] [Related]

  • 4. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
    Xiao J, Leung JC, Chan LY, Guo H, Lai KN.
    Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534
    [Abstract] [Full Text] [Related]

  • 5. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
    Zhang YF, Zou XL, Wu J, Yu XQ, Yang X.
    Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
    [Abstract] [Full Text] [Related]

  • 6. PPARγ ligand ciglitazone inhibits TNFα-induced ICAM-1 in human airway smooth muscle cells.
    Huang CD, Hsiung TC, Ho SC, Lee KY, Chan YF, Kuo LW, Lin SM, Wang CH, Lin HC, Kuo HP.
    Biomed J; 2014 Dec; 37(4):191-8. PubMed ID: 25116714
    [Abstract] [Full Text] [Related]

  • 7. Effect of eplerenone on hypertension-associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPAR-γ).
    Miana M, de Las Heras N, Rodriguez C, Sanz-Rosa D, Martin-Fernandez B, Mezzano S, Lahera V, Martinez-Gonzalez J, Cachofeiro V.
    J Physiol Pharmacol; 2011 Feb; 62(1):87-94. PubMed ID: 21451213
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells.
    Li X, Kimura H, Hirota K, Sugimoto H, Kimura N, Takahashi N, Fujii H, Yoshida H.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1041-51. PubMed ID: 17255125
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of Citral on Lipopolysaccharide-Induced Inflammation in Human Umbilical Vein Endothelial Cells.
    Song Y, Zhao H, Liu J, Fang C, Miao R.
    Inflammation; 2016 Apr; 39(2):663-71. PubMed ID: 26658749
    [Abstract] [Full Text] [Related]

  • 13. [Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].
    Zeng XL, Liu XJ, Bao HR, Zhang Y, Tan EL, Liao JM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):743-8. PubMed ID: 22321707
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta.
    Tian Q, Miyazaki R, Ichiki T, Imayama I, Inanaga K, Ohtsubo H, Yano K, Takeda K, Sunagawa K.
    Hypertension; 2009 May; 53(5):798-804. PubMed ID: 19289654
    [Abstract] [Full Text] [Related]

  • 16. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
    Zhang J, Zhang Y, Xiao F, Liu Y, Wang J, Gao H, Rong S, Yao Y, Li J, Xu G.
    Biochem Pharmacol; 2016 Feb 01; 101():100-11. PubMed ID: 26673543
    [Abstract] [Full Text] [Related]

  • 17. Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist.
    Tang SC, Leung JC, Chan LY, Tsang AW, Lai KN.
    J Am Soc Nephrol; 2006 Jun 01; 17(6):1633-43. PubMed ID: 16687627
    [Abstract] [Full Text] [Related]

  • 18. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
    Ohga S, Shikata K, Yozai K, Okada S, Ogawa D, Usui H, Wada J, Shikata Y, Makino H.
    Am J Physiol Renal Physiol; 2007 Apr 01; 292(4):F1141-50. PubMed ID: 17190910
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions.
    Kimura H, Li X, Torii K, Okada T, Takahashi N, Fujii H, Ishihara S, Yoshida H.
    Nephrol Dial Transplant; 2008 Aug 01; 23(8):2496-503. PubMed ID: 18367541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.